This content is PDF only. Please click on the PDF icon to access.
The virtual explosion of knowledge of viral hepatitis that has occurred since Blumberg's Nobel-Prize-winning discovery of hepatitis B surface antigen in the mid-1960s is one of the most exciting medical stories of our time. The study of the diseases called "viral hepatitis" has lagged far behind that of the acute viral diseases. Vaccines had been systematically developed for the common viral infections after the establishment of techniques for in-vitro cultivation of pathogenic viruses. While physicians vaccinated for polio, rubella, and mumps, they guessed at the epidemiology of viral hepatitis and argued over the value of immunoprophylaxis with immune serum globulin—but
Viral Hepatitis.. Ann Intern Med. 1979;91:146. doi: 10.7326/0003-4819-91-1-146_1
Download citation file:
Published: Ann Intern Med. 1979;91(1):146.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use